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Abstract
PRDM genes are a family of transcriptional regulators that modulate cellular processes such as differentiation, cell growth
and apoptosis. Some family members are involved in tissue or organ maturation, and are differentially expressed in specific
phases of embryonic development. PRDM5 is a recently identified family member that functions as a transcriptional
repressor and behaves as a putative tumor suppressor in different types of cancer. Using gene expression profiling, we
found that transcriptional targets of PRDM5 in human U2OS cells include critical genes involved in developmental
processes, and specifically in regulating wnt signaling. We therefore assessed PRDM5 function in vivo by performing loss-of-
function and gain-of-function experiments in zebrafish embryos. Depletion of prdm5 resulted in impairment of
morphogenetic movements during gastrulation and increased the occurrence of the masterblind phenotype in axin+/2
embryos, characterized by the loss of eyes and telencephalon. Overexpression of PRDM5 mRNA had opposite effects on the
development of anterior neural structures, and resulted in embryos with a shorter body axis due to posterior truncation, a
bigger head and abnormal somites. In situ hybridization experiments aimed at analyzing the integrity of wnt pathways
during gastrulation at the level of the prechordal plate revealed inhibition of non canonical PCP wnt signaling in embryos
overexpressing PRDM5, and over-activation of wnt/b-catenin signaling in embryos lacking Prdm5. Our data demonstrate
that PRDM5 regulates the expression of components of both canonical and non canonical wnt pathways and negatively
modulates wnt signaling in vivo.
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Introduction
The human PRDM gene family consists of 17 known members
characterized by the presence, generally at the N-terminus, of the
PR domain, related to the SET domain functioning in chromatin-
mediated transcriptional regulation [1], followed by a variable
number of zinc finger repeats. Several studies suggest that PRDM
family members are negative regulators of cell growth and
tumorigenesis [2,3,4,5,6,7], and their frequent inactivation in a
broad spectrum of tumors largely supports this hypothesis
[8,9,10,11,12,13].
PRDM5 (or PFM2) is a recently characterized member of the
PRDM family. Although its precise biological function remains to
be elucidated, inactivation of PRDM5 in different tumors suggests
that it may behave as a tumor suppressor. It is, in fact, often
silenced in cell lines derived from breast, ovarian and hepatic
tumors [7] and has been identified as a target of epigenetic
silencing in colorectal and gastric cancer [14]. PRDM5 may also
have other disease-linked functions: two PRDM5 sequence variants
were recently found in a study of neutropenic patients that lacked
mutations in genes associated to hereditary neutropenia, such as
ELA2 and GFI1 [15].
PRDM5 acts as a sequence specific DNA-binding transcription
factor, and its consensus DNA binding sequence has recently been
described [15]. Its activity derives from the association with
chromatin modifying enzymes, such as histone methyltransferase
G9A and histone deacetylase 1 (HDAC1), which are recruited to
its target promoters determining modifications in the methylation
and acetylation status of chromatin [15].
We performed gene expression profiling after PRDM5
induction in U2OS cells, and found differential expression of
genes involved in development and cell fate determination, such as
components of wnt signaling pathways. An important role for
other PRDM genes in embryonic development has been described
through functional studies in different animal models, and is
further supported by their specific and restricted pattern of
expression during development [16,17,18]. The possibility that
PRDM5, like other PRDM proteins, might regulate important
developmental processes prompted us to investigate its role in
zebrafish embryogenesis. Our results show that PRDM5 nega-
tively modulates both the canonical wnt/b-catenin pathway and
the non canonical planar cell polarity (PCP) wnt pathway in early
stages of zebrafish development.
Results
Identification of genes regulated by PRDM5 in U2OS cells
We analyzed the gene expression profile of a U2OS cell line
conditionally expressing HA-tagged PRDM5 (U2OS-PRDM5),
where PRDM5 is under the transcriptional control of a
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e4273doxycycline-inducible promoter. Expression of PRDM5 protein is
detectable after 8 hours of induction with 2 mg/ml doxycycline,
and increases steadily up to 48 hours (Figure 1A), after which cells
begin to undergo apoptosis (data not shown). U2OS cells
containing the empty cloning vector (U2OS-pSG213) were used
as controls for each condition.
Total RNA was extracted from U2OS-PRDM5 and U2OS-
pSG213 cells after 8, 24 and 48 hours of doxycycline treatment.
We performed four independent experiments for each time point
and pooled the RNAs corresponding to individual experimental
conditions. Biotinylated cRNA targets were synthesized from each
RNA pool and hybridized to Affymetrix oligonucleotide chips
(GeneChip HG-U133 Plus 2.0). Results were analyzed using
GCOS and further elaborated with proprietary software, as
described in Materials and Methods [19].
GeneChip probe sets regulated by PRDM5 at different time
points are summarized in Figure 1B. Cross comparison of results
identified 197 probe sets (59 induced and 139 repressed) that are
concordantly regulated at all time points (Table S1). The number
of target genes increases at later time points, probably due to the
increasing amount of PRDM5 protein (Figure 1A).
To determine the reliability of microarray data, a random set of
twenty genes was assayed by qPCR on an independent set of
RNAs (Figure 1C). We found concordance between GeneChip
prediction and expression level in the U2OS system for 19/20
genes (Figure 1C and Table S2).
Functional classification of PRDM5 target genes
We next performed functional classification of regulated genes
to gain insight on the cellular processes targeted by PRDM5
expression. First, we classified genes that are regulated at all time
points by collecting information from Web-based sources
(GOTM, gene ontology tree machine at http://bioinfo.vanderbilt.
edu/gotm; SOURCE at http://source.stanford.edu/cgi-bin/
source/sourceSearch; Gene and PubMed at http://www.ncbi.
nlm.nih.gov/). The enriched functional categories included cell
adhesion and development (Table S3).
Different genes encoding proteins involved in cell adhesion
(CNTN3, CNTNAP2, NINJ1) [20,21], components of extracellular
matrix (COL5A1, COL6A3, FBLN1, MFAP5) [22,23] or proteins
involved in regulation of extra cellular matrix (ECM) production
(FOXF2) [24] are down regulated, suggesting that PRDM5
negatively modulates cell-cell and cell-matrix adhesion. Expression
of the gene encoding for metalloprotease ADAMTS6 is instead
upregulated and may function by activating remodeling of ECM
[25]. Cell-cell and cell-matrix interactions play an important role
in the reception, coordination and modulation of external stimuli,
resulting in the regulation of cell growth and survival.
Different genes expressed in the nervous system and/or
involved in development are modulated by PRDM5 expression
in U2OS cells. Of particular interest, we found changes in the
expression levels of relevant components of wnt signaling
pathways. We therefore searched more extensively for genes
Figure 1. Gene expression profiling of a U2OS cell line overexpressing PRDM5. A. Western Blot analysis of PRDM5 protein expression in
the U2OS-PRDM5 clone. PRDM5 protein level was analyzed 8, 24 and 48 hours after doxycycline treatment. U2OS cells bearing the empty vector
(U2OS-pSG213) were used as control. HA-tagged PRDM5 was detected by immunoblot with an anti-HA antibody; anti-vinculin (anti-VCL) antibody
was used for normalization of protein levels. B. Number of regulated Affymetrix probe sets identified by gene expression profiling at each time point.
C–D. Expression level of PRDM5 target genes. Relative mRNA levels (logarithmic scale) of induced and repressed genes in U2OS cells after expression
of PRDM5 for 8, 24 and 48 hours, as assayed by qPCR. A collection of PRDM5 target genes randomly selected (C) or of the wnt pathways (D) is shown.
doi:10.1371/journal.pone.0004273.g001
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genes obtained at different time points, but not necessarily
common to all. We looked for components of wnt signaling
pathways as well as for wnt targets, exploiting data collected in the
Wnt Homepage (http://www.stanford.edu/,rnusse/wntwindow.
html), and found that 32 putative PRDM5 targets are included in
one of these categories (Table S4). We confirmed microarray
results through RT-PCR on a selected set of genes (Figure 1D and
Table S2).
The wnt antagonists KREMEN1 and DKK1 [26] are upregulated
upon PRDM5 expression, while two putative agonists, RSPO3 and
SOX4 [27,28], are downregulated, suggesting PRDM5 may
antagonize wnt signaling. Consistently, a decrease in PRDM5
expression in U2OS cells by shRNA results in downregulation of
KREMEN1 and upregulation of RSPO3 (data not shown). PRDM5
expression also results in decreased expression of wnt receptors
FZD1 and FZD2 and of putative wnt targets, such as CCND1, FST,
FN1 and ENC1. Genes of the non canonical PCP wnt pathway,
such as the co-receptor ROR1, are also regulated. These results
suggest a role for PRDM5 in the regulation of both canonical and
non canonical wnt signaling. Wnt signaling is involved in many
aspects of embryonic development, such as morphogenetic
movements, cell type specification and patterning. We therefore
investigated the role of PRDM5 in zebrafish development.
Expression pattern of prdm5 during zebrafish
development
Zebrafish Prdm5 protein is highly homologous to the human
protein (Figure S1) with the PR domain at the N-terminus followed
by a stretch of 16 zinc fingers (http://www.expasy.ch/prosite/). We
first analyzed the expression of prdm5 in developing zebrafish using
RT-PCR and in situ hybridization in whole embryos 30 min to
48 hours post fertilization (hpf), and in sections of larvae 2 weeks
post fertilization. A prdm5 transcript corresponding to the full length
coding region is present in the fertilized eggs and throughout
development (Figure 2A). In situ hybridization on whole embryos
ranging from 30 min to 48 hpf showed strong maternal expression
(Figure 2B), followed by ubiquitous expression after the onset of
zygotic transcription, with higher levels in the central nervous
system (CNS) at 24 hpf and 48 hpf (Figure 2BIII-IV). In situ
hybridization on sections of 2 week old fish showed that prdm5
expression isrestricted tospecifictissuesincludingintestinalmucosa,
ventral spinal chord and ciliary zone (data not shown).
Effects of prdm5 knockdown and overexpression during
embryogenesis
We next used both loss of function and gain of function
approaches to study the role of Prdm5 during zebrafish
development. We designed two morpholino oligonucleotides to
obtain a depletion of Prdm5 protein: one targeting the region
comprising the start codon (ATGmo), and one targeting the
exon1/intron1 splice site (splice blocking or SBmo). It was not
possible to assess the levels of residual protein through Western
Blotting after depletion of Prdm5 using the ATGmo due to the
lack of a suitable antibody. However, the phenotype was
comparable to that caused by the SBmo, which achieved an
almost complete block of splicing of the zygotic prdm5 mRNA
(Figure S2), predicted to result in a protein truncated at the level of
amino acid 31 (at the N-terminus of the PR domain), and
therefore predicted to be not-functional.
The effects of the two morpholinos on zebrafish development
were similar and consisted in the dose-dependent appearance of a
cyclopic phenotype (Figure 3A–D). Doses lower than 2 ng yielded
no visible phenotype, and doses higher than 10 ng resulted in
strong underdevelopment of most embryos. There was a slight
difference in the phenotypes induced by the two morpholinos. The
ATGmo induced stronger cyclopia (Figure 3B), while the SBmo
induced closer, smaller eyes and marked axial mesendodermal
defects (jaw, heart and blood defects) (Figure 3C–D). The injection
of a mixture of both morpholinos (Mix mo: 4ng ATGmo+4ng
SBmo) gave a phenotype similar to the SBmo alone (Figure 3F).
The differences in the effects of the two morpholinos possibly
reflect different roles of maternal and zygotic Prdm5 in convergent
extension (CE) movements of components of the mesendoderm.
Injection of mRNA encoding for human PRDM5 (hPRDM5)a t
doses ranging between 50 and 200 pg/embryo resulted in
embryos with a shorter body axis due to posterior truncation, a
bigger head and abnormal somites (Figure 3H), a phenotype
somehow opposite to that induced by SBmo injections.
To verify if the defects observed in embryos injected with either
prdm5 morpholinos or hPRDM5 were due to specific loss or gain of
Figure 2. Expression of prdm5 during Zebrafish development.
A. Expression of prdm5 was measured by qPCR using three pairs of
primers (3f/r, 9f/r and 11f/r) that amplify different regions of the
transcript. Relative expression levels at each developmental stage (2–8
cell stage=mat, 24 hours pf=24h, 3days pf=3d) were calculated with
respect to the average expression levels in all samples. B. Whole mount
in situ hybridization of 1 hpf (I), 9 hpf (II), 24 hpf (III) and 48 hpf (IV)
zebrafish embryos stained with a cRNA dig-labeled prdm5 probe.
Ubiquitously high expression levels are detected in the first two stages;
lower levels are present in 24 and 48 hpf.
doi:10.1371/journal.pone.0004273.g002
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mRNA (150 pg) and assessed if the phenotype induced by either
treatment was rescued. It is important to note that no sequence
similarities exist between the morpholino and the mRNA. We
found that 71/100 embryos injected with both SBmo and
hPRDM5 mRNA were normal (Figure 3I) as opposed to a very
low number of normal embryos in clutches injected only with
SBmo (8/110, Figure 3G), or only with hPRDM5 mRNA (7/130,
Figure 3H).
Effect of prdm5 depletion and hPRDM5 overexpression in
the mbl background
During gastrulation, the activation of canonical wnt/b-catenin
signaling is required for regionalization of the anterior neural plate
(ANP) that will generate telencephalic, eye field, diencephalic, and
hypothalamic fates. A gradient of b-catenin signaling determines
the identity of each domain, with high levels of signaling
promoting more caudal neural identities. Masterblind (mbl) hetero-
zygous zebrafish carry a null mutation in the axin gene, which
encodes for an essential component of the b-catenin destruction
complex. Homozygous mutants have a constitutively active
canonical wnt pathway that results in posteriorization of the
anterior brain and consequently in the absence of eyes and
telencephalon [29]. To assess the role of Prdm5 in modulating wnt
signaling, we assessed the effect of prdm5 depletion or overexpres-
sion in embryos derived from incrosses of mbl (axin+/2) carriers.
Injections of 6 ng of a mixture of both prdm5 morpholinos
increased the number of embryos displaying the mbl phenotype
from approximately 25% to .50%, thus indicating that a
reduction of prdm5 levels results in an increase of canonical wnt
signaling, and overcomes the low levels of functional axin in
heterozygotes (Table S5, Figure 3J–L). By contrast, injection of
hPRDM5 mRNA was not able to change the number of embryos
with an mbl phenotype, but induced a shorter body and a bigger
head in most embryos, regardless of the mbl phenotype. Therefore,
in axin+/2 embryos, the depletion of prdm5 determines a
significant increase in the frequency of the mbl phenotype, which
is known to derive from an increase in canonical wnt signaling.
prdm5 modulates CE movements during embryogenesis
The cyclopic phenotype observed in prdm5 depleted zebrafish
embryos could be the consequence of a block of CE movements
during gastrulation at the level of the prechordal plate [30]. To
verify this hypothesis we performed triple in situ hybridization
experiments using two different cocktails of cRNA probes: one
consists of probes for hgg1, ntl and dlx3, and serves to identify CE
defects due to impairment of the non-canonical wnt pathway [31];
the other contains probes for rx3, pax2a and ntl, and explores CE
defects deriving from impairment of the canonical wnt pathway
[32].
In normal embryos, the most anterior structure is identified by
the hatching gland (marked by hgg1 expression) that always aligns
with the border between neural and non-neural ectoderm
(marked by dlx3 expression) (Figure 4A–B). Zebrafish embryos,
uninjected (Figure 4B), injected with 6 ng SBmo (Figure 4C) or
with 150 pg hPRDM5 mRNA (Figure 4D) were stained for hgg1,
ntl and glx3 at 90% epiboly stage. After overexpression of
hPRDM5, the hatching gland is included in the neural border, an
event that correlates with defects in migration of mesendodermal
cells (Figure 4D). This behavior indicates inhibition of non
canonical PCP wnt signaling, and suggests that Prdm5 negatively
m o d u l a t e st h i sp a t h w a y .
The second cocktail stains three structures of the gastrulating
embryo: the eye/telencephalon (rx3), the mid-hindbrain border
(pax2a) and the notochord (ntl) (Figure 4E–F). Staining of zebrafish
embryos injected with 6 ng SBmo (Figure 4G) or with 150 pg
hPRDM5 mRNA (Figure 4H) with this cocktail revealed that
depletion of prdm5 induces a reduction of the distance between
eye/telencephalon and the mid-hindbrain border (Figure 4G),
which is indicative of perturbation of morphogenetic movements
as a consequence of over-activation of wnt/b-catenin signaling.
Taken together our data suggest that prdm5 inhibits wnt signaling
(both canonical and non-canonical) in the anterior CNS and
mesendoderm.
dkk1 expression is modulated by Prdm5 in early stages of
zebrafish development
Since DKK1 is upregulated by PRDM5 in U2OS cells, and
considering that injection of hPRDM5 mRNA in zebrafish
Figure 3. Phenotypic analysis of Prdm5 functions in zebrafish
development. A–F: Depletion of prdm5. Cyclopia and other axial
mesendodermal defects in prdm5 morpholino injected zebrafish
embryos. 48 hpf embryos either wild type (A,E) or injected (B: ATGmo;
C: SBmo- 4ng; D: SBmo-8ng, F: Mix mo) are shown. Arrows in C, D and F
point to mesendodermal defects. G–I: Overexpression of hPRDM5
rescues the morpholino phenotype. G: embryos injected with SBmo
morpholino; H: Injections of 100 pg hPRDM5 mRNA in zebrafish
embryos results in a ‘‘dorsalized’’ phenotype. I: Co-injection of prdm5
SBmo and hPRDM5 mRNA results in normal embryos. 48 hpf embryos
are shown. J–L: Depletion of prdm5 enhances the mbl phenotype.
Effect of prdm5 morpholino injection on the mbl phenotype. Injection
of Mix mo in embryos derived from incrosses of mbl carriers. J) wt
embryo; K) mbl homozygous mutants; L) mbl heterozygotes injected
with Mix mo. All embryos analysed at 48 hpf.
doi:10.1371/journal.pone.0004273.g003
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overexpression [33], we assessed dkk expression following prdm5
morpholino or hPRDM5 mRNA injections by in situ hybridization.
Expression of dkk1 in the two experimental conditions was
evaluated at 30% and 90% epiboly, corresponding to 3 and 6 hpf,
respectively. At both stages, injection of hPRDM5 mRNA induced
a marked increase in the level of expression of dkk1 and in the
number of presumptive mesodermal cells expressing it (Figure 5A–
B, E–F). By contrast, injection of a mixture of both morpholinos
(Mix mo: 4ng ATGmo+4ng SBmo) resulted in a reduction of dkk1
expression. (Figure 5C–D). At 90% epiboly, in the embryos
injected with hPRDM5 mRNA the increase of dkk1 expression was
predominantly in the anterior mesendodermal region (Figure 5,
upper panels of insets I–III), whereas dkk1 expression in the
presumptive tail mesoderm was strongly reduced (Figure 5, lower
panels of insets I–III). The increase of dkk1 in the head region, and
the reduction of dkk1 in the tail region of hPRDM5 mRNA injected
embryos result in the ‘‘rostralized’’ phenotype observed at 24–48
hpf. Our results suggest that regulation of dkk expression may
participate to Prdm5-dependent inhibition of canonical wnt/b-
catenin signaling.
Discussion
We investigated PRDM5 function by identifying its target genes
in U2OS cells, and we found that the two main functional
categories of genes regulated by PRDM5 are molecules involved in
cell-cell interactions and components of developmental signaling
pathways. Cell-cell interactions are relevant in modulating the
response to external stimuli, and modifications of membrane and/
or matrix components may activate signaling events that change
cell fate [34].
However, even more striking was the regulation of genes
encoding for components of developmental signaling pathways.
In particular, overexpression of PRDM5 in U2OS cells affects
the transcription of both canonical and non canonical wnt
pathway components. Wnt signaling is involved in many
aspects of embryonic development, such as morphogenetic
movements, cell type specification and patterning. Other
PRDM genes exert important functions in development, as
largely demonstrated by diverse studies in animal models
[ 1 6 , 1 7 , 1 8 ] .W et h e r e f o r ei n v e s t i g a t e dt h er o l eo fP R D M 5i n
zebrafish development.
We found that downregulation of Prdm5 expression in zebrafish
embryos affects CE movements leading to cyclopia or small eyes
and axial mesodermal defects. On the contrary, hPRDM5 mRNA
overexpression results in a big head and short body axis, similar to
the phenotype observed after overexpression of the wnt antagonist,
Dkk1. In fact, Dkk1 behaves as ‘‘head inducer’’ antagonizing the
posteriorizing effect of the canonical wnt pathway on anterior
neural structures [33]. Coherently, Dkk1 is a target of upregula-
tion by PRDM5 in U2OS cells.
The interplay between wnt/b-catenin and PCP signaling is
fundamental for correct specification of anterior neural struc-
tures. While wnt/b-catenin cascade has a posteriorizing effect on
anterior neural ectoderm and suppresses more rostral forebrain
fates, PCP signaling antagonizes wnt/b-catenin, allowing
specification of eye field and telencephalon [32]. Dkk1 acts by
interfering with wnt/b-catenin signaling and favoring PCP
signaling, thereby functioning to bridge the two pathways [33].
How Dkk1 favours PCP signalling is not clear, but it may
cooperate with the glyplican 4/6 homologue Knypek to activate
the signalling cascade. Glyplicans are cell-surface heparan sulfate
proteoglycans that exert important functions in development by
Figure 4. Analysis of CE movements at gastrulation. A, E=diagrams illustrating the staining pattern. B–D: Dorsal views of zebrafish embryos at
90% epiboly stage, stained for hgg1 (h=rostral mesendoderm), ntl (n=notochord), dlx3 (b=neural border). White dashed lines mark the dlx3 signal,
and correspond to the border between neural and non-neural ectoderm. F-H: dorsal views of zebrafish embryos at 90% epiboly stage, stained for rx3
(e+t=eye field+telencephalon), pax2a (mhb=midhindbrain boundary) and ntl (n=notochord). The embryos were uninjected (B, F), injected with
6 ng SBmo (C, G) or 150 pg hPRDM5 mRNA (D, H). White lines mark the distance between eye field and mid-hindbrain boundary.
doi:10.1371/journal.pone.0004273.g004
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pathway. Indeed, GPC3 selectively improves non-canonical
wnt/PCP signalling, while inhibiting canonical wnt signalling
in mouse models [36].
In zebrafish, Prdm5 acts by interfering with both signaling
cascades, introducing an additional level of modulation to the
complex scenario of wnt pathway regulation. We can speculate
that Prdm5-dependent inhibition of wnt/b-catenin signaling is
at least in part correlated to the increased expression of Dkk1.
How Prdm5 inhibits non-canonical PCP signaling is, instead,
unclear. Interestingly, we found that GPC1 is downregulated
upon PRDM5 expression in U2OS cells. Although a role for
GPC1 in the regulation of wnt signalling has not been reported
so far, it is possible that PRDM5 may down modulate non-
canonical wnt/PCP signalling through downregulation of
glypicans, counteracting the positive effect of Dkk1 on this
pathway.
The definition of PRDM5 as candidate tumor suppressor
derives from its frequent inactivation in human cancers and from
its ability to impair cell growth and enhance apoptosis.
Constitutive activation of wnt signaling is a common event in
human cancers, and alterations of specific pathway components
have been implicated in diverse tumor types [37]. Our results,
derived from gene expression data and functional studies in
zebrafish development, suggest that PRDM5 may exert its tumor
suppressor functions through negative modulation of wnt signal-
ing. Inactivation of PRDM5 through gene deletions, epigenetic
silencing or point mutations may therefore represent a novel
mechanism of constitutive activation of wnt signaling in human
tumors.
Materials and Methods
Cell lines
The U2OS-PRDM5 cell line was generated by stable
transfection of U2OS cells with human HA-PRDM5 cDNA cloned
in the pSG213 doxycyclin inducible vector; single clones were
selected with 1,5 mg/ml puromycin for three days and then
expanded in tetracyclin free medium. A bulk population of U2OS
cells transfected with the empty vector (U2OS-pSG213) was used
as a control. U2OS-PRDM5 and U2OS-pSG213 cells were
maintained in DMEM supplemented with 100 mg/ml streptomy-
cin, 100 mg/ml penicillin, 2 mM glutamine, 10% tetracyclin free
serum and 1,5 mg/ml puromycin at 37uC in a humidified
atmosphere containing 5% CO2. Doxycycline treatments were
performed by adding 2 mg/ml doxycycline to the culture medium
for 8, 24 or 48 hours.
Constructs
Human PRDM5 CDS was amplified by PCR using specific
primers modified at the 59 end with the sequence recognized by
BamH1 restriction enzyme (B-PR5f1: 59-(GC)GGATCCCTGG
GCATGTACGTGCCGGA-39; B-PR5r1: 59-(GC)GGATCCT-
TAGCTGTCAGCTACACCAT-39) and cloned into the BamH1
site of the pCDNA3-HA vector (Invitrogen). The HA-tagged
PRDM5 fragment was purified after digestion with SpeI and XhoI
restriction enzymes cloned into the pSG213 vector. Human
PRDM5 CDS used for RNA synthesis was cloned in the BamH1
site of pCS2+ vector. A partial zebrafish prdm5 CDS was cloned by
PCR from 25 ng of cDNA derived from 3 day post fertilization
embryos using the following primers: 59-ACATGGATGAT-
CAGCCTGGACT-39 (DRPR5-1F) and 59-TGTGTGTGCGC
ATGTGTTCGT-39 (DRPR5-12R) and cloned into pCR2.1-
TOPO vector.
Affymetrix GeneChip hybridization
U2OS-PRDM5 and U2OS-pSG213 cells were treated with
2 mg/ml doxycycline for 8, 24 and 48 hours. Four independent
inductions were performed and total RNA extracted using
the RNeasy mini kit (Qiagen) to generate RNA pools for
each condition. Biotin-labeled cRNA targets were obtained
from 5 mg of each RNA pool using Affymetrix custom kit.
GeneChip hybridization, washing, staining and scanning was
performed according to Affymetrix (Santa Clara, California,
USA). Two copies of the HG-U133 Plus 2.0 were hybridized
with each target. Results were analyzed using GCOS
(Affymetrix) and further elaborated through replica analysis
and statistical methods using the GenePicker software [19].
Raw data can be accessed from the GEO repository (http://
www.ncbi.nlm.nih.gov/geo/)with Data Set accession number
GSE10580.
Real-Time PCR
Validation of Affymetrix data was performed using the following
collection of Taqman assays-on-demand by Applied Biosystems:
CAV1: Hs00184697_m1; CCND1: Hs00277039_m1; DDIT4:
Hs00430304_g1; DKK1: Hs00183740_m1; ENC-1:
Hs00171580_m1;EPAS1:Hs00181674_m1;FZD1:Hs00268943_s1;
GPC1: Hs00892476_m1; HDAC9: Hs00206843_m1; HES1:
Figure 5. Prdm5 regulates dkk1 expression in early zebrafish
embryos. Expression of dkk1 at 30% epiboly (3 hpf) A, C, E and at 90%
epiboly (6 hpf) B, D, F and insets I–III. A, C, E and upper panels of insets
I–III are dorsal views (presumptive shield region to the right); B, D, F are
lateral views (dorsal to the top). Lower panels of insets I–III show the tail
region. A, B and inset I correspond to wt embryos, C, D and inset II to
embryos depleted for prdm5 by injection of Mix mo and E, F and inset III
to embryos injected with hPRDM5 mRNA.
doi:10.1371/journal.pone.0004273.g005
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IL24: Hs00169533_m1; IL8: Hs00174103_m1; JAG1:
Hs00164982_m1; JUN: Hs00357891_s1; KREMEN1:
Hs00230750_m1; RAD52: Hs00172536_m1; ROR1: Hs00178178_
m1; RSPO3: Hs00262176; SERPINB5: Hs00184728_m1; SOX2:
Hs00602736_s1; SOX4: Hs00268388_s1; TCF3: Hs00413032_m1;
TGFB2: Hs00234244_m1; TLE1: Hs00270768_m1; TNFRSF10B:
Hs00187196_m1; TOX: Hs00207075_m1.
Zebrafish prdm5 expression was quantified using the SYBR
green chemistry (Applied Biosystems) and three specific pairs of
oligos: primer pair 3: forward 59-GACGGGATGGGACTGTA-
CACTA-39; reverse 59-CCATGCTTTCATCCAGATCACC-39;
primer pair 9: forward 59-AGCTCACAGTCCAGTTTCCT
GCA-39; reverse 59-TGCGAGCACCACCTATATGGAT-39;
primer pair 11: forward 59-ATTCAGAGGAGAGGCCTTT
CCA-39; reverse 59-TGGCGTCACAATGGTCACACTT-39; b-
actin1: forward 59-CCACCATGAAGATCAAGATC-39; reverse
59-ACATCTGCTGGAAGGTGGA-39).
Thermal cycling parameters were: 1 cycle at 50uC for 2 min,
followed by 40 cycles in which the temperature ramp from 95uC
to 60uC in 1 min. Each sample was run in triplicate. The mean
value of replicates for each sample was calculated, expressed as
cycle threshold and, for each sample, the CT value of the
endogenous control (18S or b-actin1) was subtracted to the CT
value of the target gene (DCt) to obtain comparable values. The
relative amount of gene expression was calculated as the
difference (DDCt) between DCt of the test sample and of the
control sample. Finally, the relative expression is expressed as
2
2DDCt.
Ethics statement
Fish were maintained/raised according to EU regulations on
laboratory animals.
Strains and maintenance
Zebrafish strains were maintained and bred according to
standard procedures. Tu ¨ebingen wild-type lines and axint
m213
(previously known as masterblind (mbl)) mutant lines were used.
In situ hybridization
Whole mount and section in situ hybridization was performed
as previously described [38]. The dkk1 probe was synthesized as
previously described (Hashimoto et al., 2000). prdm5 mRNA probe
was synthesized as follows: CR2.1-TOPO-prdm5 vector was
linearized with BamH1 or HindIII restriction enzymes, in vitro
transcribed with T7 RNA polymerase, and the mRNA probe was
subsequently labeled with DIG-RNA labeling mix (Roche). Anti-
Digoxigenin-AP antibody (Roche) was then used to detect the
hybridization signals.
Antisense morpholino oligonucleotides and RNA
injection
Antisense morpholino oligonucleotides were designed (Gene-
Tools, LLC) against the first ATG of prdm5 (ATGmo) or against
the exon1-intron1 splice site, specifically targeting zygotic prdm5
(Splicing Block MO, SBmo). The sequences of ATGmo and SBmo
are 59-TCCGGCACGTACATACCCAACATCC-39 and 59-
TTATAGGCACGAACCTTCTTGACTG-39, respectively.
Human PRDM5 mRNA was synthesized from pCS2+-PRDM5
vector, previously linearized with NotI restriction enzyme. 10 mg
of linearized vector were in vitro transcribed with SP6 using the
mMessage Machine kit (Ambion). Embryos were microinjected at
1-cell stage using 50 to 200 pg of synthetic human PRDM5 capped
mRNA or 2 to 8 ng of ATGmo or SBmo.
Supporting Information
Figure S1 PRDM5 protein is well conserved during evolution.
ClustalX alignment of human (NP_061169), mouse (NP_081823)
and Zebrafish (NP_001002301) PRDM5 proteins shows it is well
conserved among human, mouse and zebrafish, with the exception
of human exon 6 coding region (red box), which is poorly
conserved between human and zebrafish and absent in the mouse
homolog. The PR domain is located between the two arrows.
Found at: doi:10.1371/journal.pone.0004273.s001 (2.89 MB TIF)
Figure S2 Efficiency of prdm5 knockdown assayed by the RT-
PCR in SB mo injected embryos. Relative expression of prdm5
was measured by RT-PCR using three pairs of primers (see
Materials and methods); relative expression at each developmental
stage (2–8 cell stage=maternal, 24 hours pf=24hpf, 3days
pf=3dpf) was calculated with respect to the not injected embryo
(C) at the same stage.
Found at: doi:10.1371/journal.pone.0004273.s002 (0.13 MB TIF)
Table S1 GeneChip probe sets regulated by PRDM5 expression
in U2OS cells.
Found at: doi:10.1371/journal.pone.0004273.s003 (0.42 MB
DOC)
Table S2 Validation of microarray results by qPCR. GeneChip
predictions are shown in the first three columns. Fold changes (FC)
predicted by Affymetrix and by qPCR are shown.
Found at: doi:10.1371/journal.pone.0004273.s004 (0.09 MB
DOC)
Table S3 Functional classification of genes regulated by
PRDM5 in U2OS cells.
Found at: doi:10.1371/journal.pone.0004273.s005 (0.16 MB
DOC)
Table S4 PRDM5 target genes of the wnt pathway.
Found at: doi:10.1371/journal.pone.0004273.s006 (0.08 MB
DOC)
Table S5 prdm5 depletion enhances masterblind phenotype in
axin+/2 zebrafish embryos. Three independent experiments of
rescue of the mbl phenotype are shown. Control: not injected
embryos; Mix mo: embryos injected with ATG and SB mo;
mRNA: embryos injected with hPRDM5 mRNA. The expected
percentage of normal or mbl embryos is shown (EXPECTED); the
number (and percentage) of embryos obtained in each experiment
and the corresponding phenotype is reported (EXP1, EXP2,
EXP3, PHENOTYPE).
Found at: doi:10.1371/journal.pone.0004273.s007 (0.04 MB
DOC)
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